NCT00644904View on ClinicalTrials.gov

Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Multiple Sclerosis
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

DIETARY_SUPPLEMENT

Vitamin D3

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

All Listed Sponsors
collaborator

Direct MS-Proactive Charity

UNKNOWN

collaborator

Multiple Sclerosis Society of Canada

OTHER

lead

University of Toronto

OTHER

NCT00644904 - Safety Trial of High Dose Oral Vitamin D3 With Calcium in Multiple Sclerosis | Biotech Hunter | Biotech Hunter